Inactivation of the PHD3-FOXO3 axis blunts the type I interferon response in microglia and ameliorates Alzheimer's disease progression

Ficheros
Estadísticas
Métricas y Citas
Metadatos
Mostrar el registro completo del ítemAutor/es
Sánchez García, Manuel A.; Lara Ureña, Nieves; March-Díaz, Rosana; Ortega-De San Luis, Clara; Quiñones-Cañete, Silvia; Mora-Romero, Bella; Barba Reyes, Juan Manuel
; Cabello-Rivera, Daniel; Romero-Molina, Carmen; Heras-Garvin, Antonio; Navarro, Victoria; López Barneo, José; Vizuete, Marisa; Vitórica, Javier; Muñoz-Cabello, Ana M.; Muñoz Manchado, Ana Belén
; Cokman, Matthew E.; Rosales-Nieves, Alicia E.; Pascual, Alberto
Fecha
2025Departamento/s
NeurocienciasFuente
Science Advances , Vol. 11, Núm. 22, 2025, eadu2244Resumen
Microglia respond to Alzheimer’s disease (AD) with varied transcriptional responses. We show that oligomeric Aß (oAß) induces the expression of Hif1a and Egln3 in microglia in vitro, together with the transcription of the type I interferon signature (IFNS) genes in a PHD3-dependent manner. We identify FOXO3 as a repressor of IFNS, whose abundance decreases upon PHD3 induction in response to oAß. In vivo, loss of PHD3 correlates with abrogation of the IFNS and activation of the disease-associated microglia signature, an increase in microglia proximity to Aß plaques and phagocytosis of both Aß and small plaques. PHD3 deficiency mitigated the Aß plaque–associated neuropathology and rescued behavioral deficits of an AD mouse model. Last, we demonstrate that microglial PHD3 overexpression in the absence of Aß pathology is sufficient to induce the IFNS and behavioral alterations. Together, our data strongly indicate that the inactivation of the PHD3-FOXO3 axis controls the microglial IFNS in a cell autonomous manner, improving AD outcome.
Materias
Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models; Animal; Disease Progression; Forkhead Box Protein O3; Humans; Hypoxia-Inducible Factor-Proline Dioxygenases; Interferon Type I; Mice; Microglia; Signal Transduction; Neurodegenerative diseases; amyloid beta protein; FoxO3 protein, mouse; interferon; transcription factor FKHRL1; Alzheimer; In-vitro; In-vivo; Interferon response; Microglia; Phagocytose; Signature genes; Transcriptional response; disease exacerbation; disease model; genetics; human; metabolism; microglia; mouse; pathology; signal transduction; TranscriptionColecciones
- Artículos Científicos [12023]
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA)
Pereyra-Rodriguez, José-Juan; Poveda, J.L.; Rivero, A.; Serra Baldrich, E.; Silvestre, J.F.; Armario Hita, José Carlos
; Calleja, M.A.; Carrascosa, J. M.; Flórez, A.; Herranz, P.; Comellas, M.; Ortiz de Frutos, F.J. (John Wiley and Sons Inc, 2024)
-
Migratory Response of Cells in Neurogenic Niches to Neuronal Death: The Onset of Harmonic Repair?
Geribaldi Doldán, Noelia
; Carrascal, Livia; Pérez García, Patricia
; Oliva Montero, José María
; Pardillo Díaz, Ricardo
; Domínguez García, Samuel
; Bernal Utrera, Carlos; Gómez Oliva, Ricardo
; Martínez Ortega, Sergio; Verástegui Escolano, Cristina
; Nunez Abades, Pedro; Castro González, Carmen
(MDPI, 2023-04-01)





